Published in Oncogene on April 20, 2006
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology (2007) 13.20
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer (2006) 6.39
MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol (2009) 5.92
Hepatocellular carcinoma: clinical frontiers and perspectives. Gut (2014) 5.79
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol (2008) 4.81
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A (2009) 4.15
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res (2008) 3.67
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene (2009) 3.51
MiRNAs and cancer. Am J Pathol (2009) 3.42
MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res (2010) 2.83
MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. PLoS One (2008) 2.82
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis (2010) 2.46
MicroRNA and cancer--focus on apoptosis. J Cell Mol Med (2009) 2.44
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev (2009) 2.41
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer (2010) 2.33
NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol (2013) 2.20
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res (2009) 2.13
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (2009) 2.12
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol (2010) 2.05
MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol (2013) 2.04
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol (2012) 2.02
miRNA profiling of cancer. Curr Opin Genet Dev (2013) 1.99
MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med (2008) 1.99
Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One (2011) 1.98
MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett (2009) 1.92
A simple array platform for microRNA analysis and its application in mouse tissues. RNA (2007) 1.91
Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) (2011) 1.91
Roles of small RNAs in tumor formation. Trends Mol Med (2010) 1.89
MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem (2011) 1.88
Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res (2009) 1.84
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res (2009) 1.84
MicroRNAs in tumorigenesis: a primer. Am J Pathol (2007) 1.83
The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One (2011) 1.81
Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer (2010) 1.74
MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73
MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One (2009) 1.73
Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol (2013) 1.73
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest (2007) 1.72
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res (2009) 1.66
MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol (2010) 1.62
Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol (2010) 1.58
Progress in microRNA delivery. J Control Release (2013) 1.58
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res (2010) 1.56
MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics (2009) 1.55
The role of microRNAs in cancer. Yale J Biol Med (2006) 1.54
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer (2010) 1.51
miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res (2011) 1.51
miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med (2012) 1.49
Deep sequencing of chicken microRNAs. BMC Genomics (2008) 1.48
MicroRNA expression variability in human cervical tissues. PLoS One (2010) 1.47
New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res (2010) 1.46
Emerging role of microRNAs in liver diseases. World J Gastroenterol (2009) 1.45
MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly (2009) 1.43
MicroRNA signatures in liver diseases. World J Gastroenterol (2009) 1.43
Exosomes: small vesicles with big roles in hepatocellular carcinoma. Oncotarget (2016) 1.43
microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med (2007) 1.43
Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett (2009) 1.42
MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci (2008) 1.41
The clinical potential of microRNAs. J Hematol Oncol (2010) 1.39
Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res (2009) 1.35
MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology (2009) 1.34
The role of microRNAs in human liver cancers. Semin Oncol (2011) 1.34
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun (2010) 1.30
MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One (2010) 1.30
Non-coding RNAs: a key to future personalized molecular therapy? Genome Med (2010) 1.29
Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One (2012) 1.28
Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer (2013) 1.27
MicroRNAs and the regulation of vector tropism. Mol Ther (2008) 1.25
Regulation of microRNA processing in development, differentiation and cancer. J Cell Mol Med (2008) 1.25
Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res (2012) 1.24
The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci (2012) 1.24
MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J (2012) 1.24
Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet (2010) 1.23
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett (2010) 1.22
Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer (2009) 1.21
MicroRNAs and liver disease. Transl Res (2011) 1.21
Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation (2008) 1.21
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One (2012) 1.20
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. PLoS One (2013) 1.19
Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res (2012) 1.19
Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med (2008) 1.19
Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst (2015) 1.18
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ (2014) 1.17
Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin Cancer Res (2010) 1.17
MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology (2008) 1.16
MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal (2013) 1.16
Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One (2012) 1.15
Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int (2011) 1.14
Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci (2008) 1.13
microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget (2015) 1.12
Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol (2015) 1.11
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 7.35
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A (1991) 7.15
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Identification of the coding sequence for a reverse transcriptase-like enzyme in a transposable genetic element in Drosophila melanogaster. Nature (1985) 4.31
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A (1993) 3.68
Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc Natl Acad Sci U S A (1986) 3.60
Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol (1995) 3.41
Structure of the 3' terminus of the hepatitis C virus genome. J Virol (1996) 3.40
Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science (1984) 3.39
Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun (1991) 3.09
Retrovirus-like particles containing RNA homologous to the transposable element copia in Drosophila melanogaster. Nature (1983) 3.07
Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus. EMBO J (1985) 3.02
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun (1994) 2.89
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology (2001) 2.80
Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol (1995) 2.76
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol (1993) 2.74
Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II. Proc Natl Acad Sci U S A (1984) 2.67
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun (1995) 2.58
Two cases of early gallbladder cancer incidentally discovered by laparoscopic cholecystectomy. Surg Laparosc Endosc (1995) 2.57
Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res (1992) 2.56
Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 2.49
Insertion of a movable genetic element, 297, into the T-A-T-A box for the H3 histone gene in Drosophila melanogaster. Proc Natl Acad Sci U S A (1982) 2.49
Importance of 5'-terminal blocking structure to stabilize mRNA in eukaryotic protein synthesis. Proc Natl Acad Sci U S A (1977) 2.45
Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (1982) 2.38
Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol (1994) 2.38
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (1998) 2.24
The nucleotide sequences of copia and copia-related RNA in Drosophila virus-like particles. Nature (1985) 2.23
Dynamics of hepatitis C viremia following interferon-alpha administration. J Infect Dis (1998) 2.18
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome. Proc Natl Acad Sci U S A (1984) 2.10
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology (1997) 2.07
Outer dense fiber 2 is a widespread centrosome scaffold component preferentially associated with mother centrioles: its identification from isolated centrosomes. Mol Biol Cell (2001) 2.04
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
Preoperative intradermal acupuncture reduces postoperative pain, nausea and vomiting, analgesic requirement, and sympathoadrenal responses. Anesthesiology (2001) 2.00
Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol (1995) 1.97
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic. Antimicrob Agents Chemother (1982) 1.87
A precision measurement of the mass of the top quark. Nature (2004) 1.87
The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet (1999) 1.87
Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol (2006) 1.84
Complete nucleotide sequence and genome organization of a Drosophila transposable genetic element, 297. Eur J Biochem (1986) 1.83
A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun (1992) 1.82
Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I. J Virol (1991) 1.80
Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res (2001) 1.79
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med (1994) 1.74
Solid and papillary neoplasm arising from an ectopic pancreas in the mesocolon. Am J Gastroenterol (1990) 1.74
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72
No apparent nucleotide sequence specificity in cellular DNA juxtaposed to retrovirus proviruses. Proc Natl Acad Sci U S A (1980) 1.72
Dual Bar homeo box genes of Drosophila required in two photoreceptor cells, R1 and R6, and primary pigment cells for normal eye development. Genes Dev (1992) 1.70
Spontaneous variation and synthesis in the U3 region of the long terminal repeat of an avian retrovirus. J Virol (1982) 1.69
Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart (2003) 1.69
Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res (1992) 1.68
Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol (1990) 1.67
Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology (1993) 1.67
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66
Synthesis of apoferritin in mouse peritoneal macrophages. Characterization of 20 S particles. J Biochem (1976) 1.65
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest (1998) 1.65
Close relationship between the long terminal repeats of avian leukosis-sarcoma virus and copia-like movable genetic elements of Drosophila. Proc Natl Acad Sci U S A (1983) 1.64
Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X. J Virol (1997) 1.61
Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett (2000) 1.58
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol (1999) 1.58
Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol (1994) 1.57
Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun (1992) 1.57
Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood (2000) 1.56
Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J Bacteriol (1996) 1.56
Nucleotide sequence characterization of a Drosophila retrotransposon, 412. Eur J Biochem (1986) 1.56
Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol (1990) 1.55
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation (1986) 1.55
Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1999) 1.54
Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun (1995) 1.54
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J (1997) 1.54
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. Development (1993) 1.53
Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol (1994) 1.52
Dramatic response of postthymomectomy myasthenia gravis with multiple lung nodules to corticosteroids. Ann Thorac Surg (1997) 1.52
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol (1993) 1.51
Sequence-specific insertion of the Drosophila transposable genetic element 17.6. Nature (1984) 1.51
Measurement of unsteady state growth rates of micro-organisms. Nature (1965) 1.51
Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology (2000) 1.49
Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res Hum Retroviruses (1989) 1.48
Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol (1992) 1.47
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem (1985) 1.47
Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions. J Biochem (1986) 1.47
Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46
Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol (1994) 1.45